Cognitive Behavioral Therapy (CBT) for PTSD in Veterans With Co-Occurring SUDs
NCT ID: NCT01357577
Last Updated: 2020-01-29
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
129 participants
INTERVENTIONAL
2013-01-01
2017-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
One hundred-sixty Veterans from 3 sites who have both PTSD and substance use disorders will be in the study. In order to know if the PTSD treatment is helpful, half of the Veterans in this study will receive PTSD treatment and half will continue to get their usual mental health and/or substance abuse treatment. Who gets which treatment will be decided by a random process. The investigators will then compare the 2 groups to see if there are differences in their PTSD symptoms.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Psychotherapy for PTSD Among Veterans Also Receiving Drug or Alcohol Treatment
NCT04581434
Integrated Cognitive Behavioral Therapy (ICBT) for Posttraumatic Stress Disorder (PTSD) and Substance Use Disorders
NCT01457404
Web-based CBT for Recent Veterans Experiencing Problems With Trauma Symptoms or Alcohol/Drug Use
NCT01710943
Integrated CBT to Improve Functioning in Veterans With Anxiety and Substance Use
NCT04871100
Intervention for Veterans With Depression, Substance Disorder, and Trauma
NCT00958217
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Arm 1: TAU + CBT
The experimental group will receive treatment as usual (TAU) plus cognitive behavioral therapy (CBT).
Cognitive behavioral therapy for PTSD
The CBT for PTSD model is based on modern theories of posttraumatic reactions that place a premium on the importance of individuals' appraisals of traumatic events, their own reactions and those of others, and the meaning of the experience in terms of oneself and one's place in the world. In addition, the model employs cognitive restructuring to teach individuals how to examine and challenge their trauma-related appraisals.
Arm 2: TAU
The "no intervention" group will receive treatment as usual (TAU).
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Cognitive behavioral therapy for PTSD
The CBT for PTSD model is based on modern theories of posttraumatic reactions that place a premium on the importance of individuals' appraisals of traumatic events, their own reactions and those of others, and the meaning of the experience in terms of oneself and one's place in the world. In addition, the model employs cognitive restructuring to teach individuals how to examine and challenge their trauma-related appraisals.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Current SUD diagnosis.
* Score of at least 45 on CAPS.
* Must speak English.
* Must agree to be taped.
Exclusion Criteria
* Severe suicidality.
* Individuals with unstable medical or legal situations that would make completion of the study highly unlikely.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
VA Office of Research and Development
FED
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jessica L Hamblen, PhD
Role: PRINCIPAL_INVESTIGATOR
White River Junction VA Medical Center, White River Junction, VT
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
James A. Haley Veterans' Hospital, Tampa, FL
Tampa, Florida, United States
Syracuse VA Medical Center, Syracuse, NY
Syracuse, New York, United States
White River Junction VA Medical Center, White River Junction, VT
White River Junction, Vermont, United States
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SPLA-01-S09
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.